Clinical trial
Efficacy and Safety of Wuling San on Breast Cancer-related Lymphedema
NCT02726477 is registered in ClinicalTrials.gov with Fourth Affiliated Hospital of Guangxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Wuling San on Breast Cancer-related Lymphedema
- Lead sponsor
- Fourth Affiliated Hospital of Guangxi Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2016
- Completion date
- May 31, 2018
- Enrollment
- 200 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, lymphedema